What hinders minority ethnic access to cancer genetics services and what may help?

Abstract

Ethnic disparities in use of cancer genetics services raise concerns about equitable opportunity to benefit from familial cancer risk assessment, improved survival and quality of life. This paper considers available research to explore what may hinder or facilitate minority ethnic access to cancer genetics services. We sought to inform service development for people of South Asian, African or Irish origin at risk of familial breast, ovarian, colorectal and prostate cancers in the UK. Relevant studies from the UK, North America and Australasia were identified from six electronic research databases. Current evidence is limited but suggests low awareness and understanding of familial cancer risk among minority ethnic communities studied. Socio-cultural variations in beliefs, notably stigma about cancer or inherited risk of cancer, are identified. These factors may affect seeking of advice from providers and disparities in referral. Achieving effective cross-cultural communication in the complex contexts of both cancer and genetics counselling, whether between individuals and providers, when mediated by third party interpreters, or within families, pose further challenges. Some promising experience of facilitating minority ethnic access has been gained by introduction of culturally sensitive provider and counselling initiatives, and by enabling patient self-referral. However, further research to inform and assess these interventions, and others that address the range of challenges identified for cancer genetics services are needed. This should be based on a more comprehensive understanding of what happens at differing points of access and interaction at community, cancer care and genetic service levels.

INTRODUCTION

Cancer genetic services offer important opportunities to benefit from assessment of familial cancer risk, with further testing and screening where appropriate.¹ Inherited mutations account for up to 10% of breast cancers, in particular BRCA1 and 2 (breast cancer, early onset),² with 5% of ovarian cancer attributed to BRCA1 mutations.³ Up to 5% of prostate cancer, particularly that affecting younger men, occurs in BRCA1 and BRCA2 carriers,⁴ while a family history of hereditary prostate cancer confers a five to eleven fold increased risk.⁵ Some 3–5% of colorectal cancer is currently attributed to identified mutations, and the risk of developing associated cancer syndromes is high.^{6, 7} Existing interventions can improve survival and quality of life following targeted screening and early diagnosis in those identified at higher familial risk.^{8, 9, 10, 11, 12} Cancer genetic assessment can also reduce psychological distress and improve knowledge of breast cancer, genetics and understanding of risk.¹³

Despite these benefits, people from minority ethnic communities appear poorly represented in genetics services. In particular, measurable ethnic disparities in use of genetic testing and counselling have been observed in cancer genetics.^{14, 15} It is possible that in the past this was partially due to lower cancer rates in family members both in the Western world and in the country of biological origin. However, disproportionately low minority uptake in genetic counselling has been observed when the family history of breast cancer is similar to that of the white population, for example, in the USA,¹⁴ and in Holland, where referrals were half of that expected given population demographics.¹⁶ Mutations in Mendelian cancer susceptibility genes have been detected in different ethnic groups at a similar frequency in a number of studies.¹⁷ Thus, the lower proportion of familial cancer susceptibility referrals for black and minority ethnic groups are unlikely to be due to differences in inherited familial cancer susceptibility.

Inequitable access across medical genetics services has raised international¹⁸ concerns to better understand how issues such as ethnicity may affect use of genetic services¹⁹ The wider socio-economic influences on ethnic variations in access to health care are well recognised.²⁰ However, issues more specific to particular health-care contexts for minority communities should not be ignored,²¹ as these may be more amenable to being addressed by service improvement. We sought to inform the development of service interventions for people of South Asian, African or Irish origin at risk of familial breast/ovarian, colorectal and prostate cancers in the UK. As a first phase of informing future interventions, we aimed to identify and consider current evidence on what may facilitate or hinder minority ethnic access to cancer genetics services in English-speaking developed countries.

METHODS

Relevant evidence was identified from six electronic sources from their inception to March 2012 (Embase; Medline; CINAHL (Cumulative Index to Nursing and Allied Health Literature); PsychINFO; Cochrane Reviews; Web of Knowledge/Web of Science). We combined terms relating to: access to health care, cancer genetics services, genetic testing and counselling, minority ethnic groups and common hereditary cancers. We sought primary quantitative and qualitative research studies involving adults aged 18–70 years of either gender, with or at risk of familial breast or ovarian, colorectal or prostate cancer; and who were of African descent, White Irish or South Asian origin (people born in, or descended from those born in Pakistan, India, Bangladesh or Sri Lanka). These are among the most common minority communities in the UK where evidence of poor access, particularly to secondary health care exists. We sought studies reported in English from North America, UK and Australasia, and included search of author citations from papers obtained and bibliographies of individual papers.

Titles and abstracts of 795 papers were reviewed (766 identified from search strategy and 29 through citation), resulting in identification of 21 potentially relevant papers at full text. These were reviewed independently by two researchers who agreed upon 11 studies containing data germane to our aim, comprising two entirely qualitative,^{22, 23} two mixed methods^{24, 25} and seven quantitative reports,^{1, 26, 27, 28} with four of the eleven studies involving service pilot interventions.^{22, 25, 29, 30} These are summarised in Table 1. Study reports and data were examined by three researchers. While published evidence was modest, with several limitations (Table 1), it was possible to identify insights and themes from qualitative studies based on a thematic network approach, exploring and categorising findings across studies in order to integrate these into global themes.³¹ Existing quantitative data were limited and heterogeneous and were used to triangulate and identify relevance of themes where possible, rather than to quantify the outcomes. A lack of primary qualitative data presented in most reports militated against possibilities for substantive meta-synthesis.³² Common themes were thus developed into a descriptive narrative for this paper.³³

Table 1. Summary of included studies.

Author, year, location, settings	Study design Data collection and/or method of analysis	Total participants Ethnic Groups (number and/or %)	Cancer genetic service	Key findings	Study limitations Other comments
Qualitative studies
Atkin et al 22 (2009) UK Primary care	Qualitative in-depth interviews. Thematic analysis	52 women diagnosed with breast cancer and 5 people with other cancers Not all participants had accessed genetic service South Asians (n=35) White British (n=22)	Primary care-based genetic service led by GP (family physician) with Special Interest in Genetics and genetic counsellor Full genetic counselling provided in community setting	• South Asians: lacked awareness of service; cultural taboos and stigma prevented people speaking to family members about cancer and inheritance patterns • Knowledge of cancer appeared lower among South Asians compared with white participants • South Asians accessing the service: experienced poor communication from professionals and wanted a more direct approach to receiving information, which they found vague; and decision-making could be compromised when interpreters are involved	Included 11 interviewed in languages other than English Qualitative study linked to observational study of service29
Ford et al23 (2007) USA Secondary care	Focus groups Content analysis	20 women with above average risk for breast cancer aged ≤50 years African American (n=13) White ‘Caucasian'(n=7)	Integrated primary and specialty service	• Barriers expressed by women who did not receive genetic counselling included: stigma; uncertainty if breast cancer could be prevented by genetic testing; and failure to see the benefits of genetic counselling • Women who received cancer genetic counselling expressed: increased fear and worry about being diagnosed with breast cancer and associated it with death; concern and mistrust about revealing family health information; and faith in the positive role of God in engaging in risk assessment	People without medical insurance or under-insured were not represented in sample
Matthews et al24 2000 USA Secondary care	Focus groups Thematic analysis	Women (n=13) with either personal or family history of breast/ovarian, colon, or prostate cancer Men (n=8) without personal or family history of these cancers All African descent (n=21)	Familial cancer risk assessment service	• Cancer equated with ‘death sentence' and fatalistic views led to screening avoidance • Participation in genetic testing prevented by: distrust and fear of hospitals, modern medicine, being experimented on; anticipated negative emotions/anxiety • Lack of discussion in families of cancer-related issues • Mistrust of use of information • Lengthy process of genetic counselling/testing and complex educational material acted as barriers	Analysis does not differentiate between participants with cancer and those referred to cancer genetics due to familial risk Included cross-sectional patient survey (see below)24
Quantitative studies
Fraser et al26 (2003) UK Secondary care	Cross-sectional self-completed survey (prior to attending clinic)	162 newly referred patients 2.5% reported ethnicity as non-white	Five regional cancer genetics service in England	• Low proportion of referrals involving non-white patients • 55% patients instigated and sought genetics referral from a provider themselves • 52% referred to genetics service by primary care provider (GP) • 38% referred to genetics service by hospital doctors • 2.5% self-referred to genetics service
Wonderling et al1 (2001) UK Secondary care	Cross-sectional self-completed survey (attending clinic) Provider survey of activity during 4 week period	Patients n=869 97% of service users: white Providers n=22	UK Cancer Genetic Services in 1998	• Only 3% reported ethnicity as non-white (almost half-Jewish ancestry) • 49% referrals from GPs • 47% referrals from hospital doctors • Some self-referrals	Little descriptive data for ethnic minorities
Sussner et al27 (2009) USA Secondary care	Cross-sectional Patient telephone survey Univariate and multivariate analysis of predictors of perceived barriers to genetic testing	146 women at increased risk of breast/ovarian cancer 100% African descent (56% US born)	Cancer genetic clinic in New York area	• Perceived barriers to genetic testing (as indicated by avoidance of breast cancer distress symptoms) include confidentiality concerns and family-related guilt Further associations include: • Stigma (with age a strong predictor) • Education (and note foreign-born had less educations) • More anticipation of negative emotions and distress associated with genetic testing for foreign-born women	Small sample size and cohort with higher educational, medical insurance and income status
Gulzar et al25 (2007) UK Primary and secondary care	Cross-sectional self-completed satisfaction survey GP satisfaction survey to 5 primary care clinics Routine data collection of referral activity Descriptive analysis	Patients (n=81) GPs (n=18)	Nurse-led cancer genetic clinics: four primary care-based and two hospital-based in London area (self-referral and proactive identification by GPs)	Overall, of 137 of referrals 17% involved people from ethnic minorities and of these 74% (n=17) self-referred compared to 89% (n=102) white self-referral Patient satisfaction survey: all respondents stated English as language of choice, language not mentioned as a barrier From two focus groups with 9 participants issues were raised regarding their post-clinic letter • Some patients wanted more statistical facts presented • Some were unwilling to share the information in the letter with their family	Minority ethnic composition of catchment population unclear Information for specific minority groups not available from patient or GP survey Project actively sought to recruit patients from minority populations (eg literature and counsellors multilingual) and in London districts with high proportion of ethnic minorities
Srinivasa et al29 (2007) UK Primary care	Before and after observation study Descriptive analysis	Referred patients No data on ethnicity of service users. 7% of the region ethnic minorities, predominately South Asian, with greater proportion in study area	Primary care-based genetic service led by GP with Special Interest in Genetics and genetic counsellor in North Kirklees district of Yorkshire, England 2004–2006	Ethnic minorities accessing regional genetic service increased from 0% at baseline to 6% at 2 years after introduction of the service. The 6% comprised six families	Percentages difficult to interpret as no denominator supplied at baseline or follow-up Linked to qualitative study above (Atkin et al22) Modest uptake for amount of resources deployed in demonstration project
Jacobs et al30 (2007) UK Primary care (and community settings)	Cross-sectional Patient self-completed satisfaction survey Routine data collection of referral activity	Patients (n=71)	Nurse-led familial cancer risk assessment service in the local community in two districts of London Patient access service through self-referral or through community-based health professionals 2005–2006	Patient survey: • 99% found service helpful • 96% found easy to access location • 94% found appointment time convenient • Ethnicity not reported Routine data: 415 patients seen in community clinics 46% referral non-White, 30% of these patients defined their origin as one of Black ethnic groups 194 patients of 415 seen were assessed as moderate or high risk of breast cancer/complex family history and 70/415 patients at moderate or high risk of colorectal cancer/complex family history. Ethnicity not reported	Although proportion of ethnic minorities recruited not identified, study was in a district with a high proportion of ethnic minorities (47% residents African Caribbean and other ethnic groups) People were invited to phone in to make an appointment which may have been a barrier for non-English-speaking members of the community
Hughes et al34 (2003) USA Secondary care	Structured telephone interview preceding genetic risk assessment for breast cancer Data from study records Descriptive analysis	28 self-referred women with >10 probability of BRACA1/2 gene 100% African descent	Genetic counselling and testing service at a cancer centre in Washington	61% (17) participated in risk assessment Comparing those that participated in genetic risk assessment to non responders • More fatalistic • More positive about preparing for the future (positive temporal orientation) • When considering using faith to cope with difficult situations: 70% of those that used faith participated in genetic risk assessment whereas this fell to 20% in those who did not utilise this approach Further: 41% who endorsed familial interdependence received BRCA1/2 test results (acceptors) compared to 91% who did not endorse this belief	Small sample size and recruited older, higher income and well educated women
Culver et al28 (2001) USA Secondary care	Interviewer-completed patient survey Descriptive analysis and logistic regression analysis of the predictors for accepting genetic counselling	97 self-referred women, recruited through paper and internet publicity, both with or without; European Americans (n=37), African Americans (n=15), Native Americans (n=15) and Ashkenazi Jewish (n=30)	Offered free genetic counselling as participants identified at increased familial risk for breast cancer Seattle area 1996–1998	Sociodemographic profile • Correlation between educational level and acceptance of genetic counselling • Only 13% of African Americans had completed college compared with 73% Ashkenazi Jewish women Uptake of service • In recruited women no difference in acceptance rate for genetic counselling (overall 52%) between ethnic groups, when adjusted for education status. Interest in genetic counselling was demonstrated for all ethnicities	Self-referred sample not representative of population Accepted 5 women with education beyond undergraduate degree and 1 with less than a high school degree following attempt to recruit women within restricted educational criteria
Matthews et al24 (2000) USA Secondary care	Cross-sectional postal survey Descriptive analysis	Women (n=13) with either personal or family history of breast/ovarian, colon, or prostate cancer Men (n=8) without personal or family history of these cancers. Participants recruited through paper and radio publicity 100% African descent	Familial cancer risk assessment service	Strong family history of cancer in recruited cohort (25% had 2+ affected relatives) but only: 10 (48%) of 21 discussed cancer within the family: 14 (67%) had annual medical check up; 12 (57%) had annual cancer screen Awareness of increased morbidity for breast and prostate cancer in African Americans: 13 (62%) knew risks in men and 14 (67%) in women Important factors affecting decision to participate in genetic testing: risk of cancer for family members; effects on family/themselves of test results; knowledge of whether other family members need testing; future planning; and test accuracy	Self-referred participants and small sample size Qualitative results reported above (see Matthews et al24)

Results

Barriers and facilitators to minority ethnic access to cancer genetics services were identified within four broad themes developed from study data: cultural variations in beliefs about cancer and inheritance; awareness of risk and accessing assessment; cross-cultural communication and facilitating engagement and uptake.

Cultural variation in beliefs about cancer and inheritance

Cultural variation in beliefs about cancer and inheritance offered potential barriers to accessing cancer genetics assessment. For example, stigma from a cancer diagnosis or from the notion of being at risk of familial cancer was found in studies involving South Asian and African origin communities.^{24, 25, 27, 29} Atkin et al,²² evaluating access to a genetics service pilot, highlight taboos about cancer among South Asian communities including refraining from using the word ‘cancer'. South Asians had less knowledge of cancer than the white majority, believed cancer to be a condition affecting white women and could equate cancer with death, as did some African Americans.^{23, 24}

Fatalistic views that nothing could be done if one developed cancer because of a family history of cancer were found among some South Asians²² and some African Americans, which led to the avoidance of screening.²⁴ Similarly, Ford et al³⁴ found African Americans who had a more fatalistic view about their risk of breast cancer were unwilling to receive genetic counselling. Familial interdependence (not thinking of oneself as separate from family) was also associated with African American women having a more negative attitude towards genetic counselling and testing.

On the other hand, religious faith in opportunities such as cancer screening and genetic counselling appeared to motivate some African American women to engage in assessment for familial cancer risk,²³ or be more positive toward genetic risk assessment and counselling, and about the value of information about genetic cancer risk.³⁴

Awareness of familial cancer risk and accessing assessment

Minority ethnic representation in cancer genetics services was identified to remain at ∼2.5–3% in the UK during the past decade^{1, 26} including within localities of high African-Caribbean³⁰ or South Asian density,²⁸ although minority ethnic communities have risen to 14% of the UK population in the same period.³⁵

Interest in breast cancer genetic counselling was identified in people of African American, Native American and European American ethnicities in one US city,²⁸ but people from ethnic minority groups appeared largely unaware of genetic cancer services, for example in the UK.^{22, 30} Other barriers to access were identified, for example, African Americans at higher breast cancer risk not wanting genetic counselling feared a cancer diagnosis.²³ Anticipation of negative emotions was related to avoidance of genetic testing²⁴ in addition to concerns about confidentiality among women of African descent who had less education and income than US-born women.²⁷ Similarly, Culver et al²⁸ found interest in, and acceptance of, free breast cancer genetic risk assessment was greatest in more educated women with a family history of breast cancer and relatively less among African Americans with lower educational opportunity or attainment.

Concern about personal risk and awareness of family history appeared drivers for referral and interest in genetic assessment among the general population,²⁶ with studies suggesting much may thus rely on initiation by the patient.^{22, 25, 26} Atkin et al²² found that patients concerned about family history of cancer expected primary care providers to provide information about cancer genetics risk assessment but related referral was found to vary significantly.^{26, 30} Many referrals not only occurred for people at lower risk for common familial cancers^{1, 26} but were more likely to be for white patients.²² Variation in use of family history questionnaires, for triage prior to genetic cancer risk assessment, appeared a further potential barrier to accessing cancer genetics services.¹ Indeed, one study found some patients may be confused about why providing family history information may yield risk estimation for certain cancers.²²

Encouraging patient self-referral showed some promise^{25, 30} with cancer genetic risk being assessed as no higher in patients referred by physicians compared with patients who self-referred.²⁵ However, communication appeared to remain an enduring challenge for access, including practical issues such as sharing the same language when making appointments by telephone.^{25, 30} Moreover, language barriers at the point of taking a family history may have resulted in failure to identify a significant history of familial cancer.²⁹

Cross-cultural communication

In the context of cancer genetics, people of South Asian origin have reported feeling some service interpreters were making decisions on their behalf, or selectively choosing what information to translate to them. Use of family members as interpreters who themselves may be at increased familial cancer risk was also stressful for people and no less problematic.²²

Despite advantages for access of seeing genetics practitioners with bilingual skills in pilot community clinics,²⁹ people of South Asian origin still experienced uncertainty, feeling information they were given was too vague. They felt consultations were too professional-centred and focused on the collection of information rather than explaining why this might be useful.²² Additionally, South Asians preferred more direct explanations and advice about risk and interventions that would have enabled them to discuss the issue more readily with relatives, rather than concentrating on provision of information about their probability of developing cancer.²²

After cancer genetic counselling, some African American women found that greater knowledge and education about their personal breast cancer risk was reassuring and were positive about enhancing vigilance through breast cancer screening, though worry about being diagnosed with breast cancer increased.²³ However, others at increased risk of breast cancer doubted the value of the information they had received if it did not prevent cancer, and did not perceive the importance of paternal health history.²³ Moreover, mistrust of how their health information would be used was identified as a barrier for African American women having cancer genetic counselling with health care professionals who were not known to them.²³

Considering communication with wider family there was unwillingness to discuss cancer even in families with a strong family history among African Americans, possibly associated with uncertainty about the usefulness of preventive or treatment options.²⁴ People of South Asian origin reported reluctance to communicate a cancer diagnosis due not only to stigma, but also when communication between women and men may be considered culturally inappropriate.²² In this context, some also had concerns about health professionals being focused on their confidentiality as individual patients, rather than assisting them with the challenges of conveying information about familial cancer risk to family members.

Facilitating engagement and uptake

Some relatively positive experience has arisen from several pilot cancer genetics service developments.^{25, 29, 30} Examples included talks at faith centres, cultural events, use of local newspapers and radio and a service linked website supported by translated leaflets to raise awareness of familial cancer, in addition to making services community located.^{25, 28, 30} While these approaches appeared acceptable to target communities, they alone have not been associated with significant increase in minority ethnic engagement or service uptake.²⁹

However, encouraging patient self-referral has shown some promise in enhancing uptake,^{25, 30} alongside use of self-triage questions about risk,³⁰ and considering flexibility in clinic times.^{25, 29, 30} In particular, deploying providers with cultural and linguistic backgrounds shared with target populations can improve satisfaction with cancer genetic services and be helpful in reducing religious sensitivities when communicating bad news, for example in some South Asian communities.^{22, 29}

Closer collaboration between cancer genetics services, primary care and cancer care providers, tailored to local populations may also improve access. This has included placing services in the local community together with enhanced training and awareness of familial cancer risk for health-care professionals,^{25, 29, 30} including identification of patients at familial cancer risk by primary care clinicians.²⁵ One community-based pilot service, seeing self-referred patients and supported by dedicated interpreting for patients, used shared computerised pedigree software to seamlessly transfer information to a regional genetics service if patients then needed further specialist assessment.³⁰

DISCUSSION

The available research suggests minority ethnic access to cancer genetics assessment may be hindered by low community awareness and understanding of familial cancer risk, and socio-cultural variations in beliefs, notably stigma about cancer or inherited risk of cancer. These factors may affect seeking of advice from providers and contribute to disparities in referral. Cross-cultural communication between individuals and providers, including when mediated by third-party interpreters, or communication within families, in the complex contexts of cancer and genetic counselling, pose several further challenges. Some promising experience of facilitating access has been gained by introduction of culturally sensitive provider and counselling interventions in cancer genetics service developments, and by enabling patient self-referral.

Strengths and limitations

Up until a decade ago, empirical work in this field largely concerned African Americans.³⁶ The research now considered here has grown to include a wider range of minority ethnic communities, including those from Asian backgrounds and from outside North America. This provides useful information to inform future intervention development and research, but the relative paucity and limitations of available evidence should still be recognised. Themes presented in this paper must be interpreted with regard to the particular study contexts and the minority communities of concern, as described and reported within them. We found qualitative studies offered helpful insights into what may shape access. However, with some exceptions,²² there were little primary data on direct patient experience presented in reports, militating against possibilities for substantive meta-synthesis.³² Data available from quantitative studies were limited and heterogeneous, mostly from observational surveys, with small or convenience samples limiting generalisability, and could not be pooled.

Relation to other work

People's understanding of genetics,^{37, 38} knowledge of cancer and terms used,³⁹ and inherited cancer⁴⁰ has been recognised to be generally low among diverse ethnic populations. Cultural variations in perceptions of which relatives constitute close family members have been identified, for example among Chinese Australians,⁴¹ underlining how patterns of inheritance for disease may be variably understood, and consistent with the confusion about this noted here.²³ Other evidence also suggests differing kinship systems may affect the way people view inheritance, and thus genetic counselling, because of family privacy,^{36, 42} or highlights cultural differences in people's advice seeking about cancer.⁴³

Concerns about how genetic cancer risk information might be used by health providers has also been identified elsewhere among African Americans.³⁷ Other experience lends further support to the prospect that access to genetics cancer services may be enhanced by cultural adaptations, including, for example, development of communication aids⁴⁴ or culturally tailored genetic counselling for Latinas or Maori people.^{45, 46}

Implications for intervention development and research

Cancer rates in South Asia are rising⁴⁷ and will increase the proportion of migrant patients in the Western world having a significant family history, who may then be eligible for a referral to a familial cancer susceptibility clinic. In addition, while the prevalence of cancers among immigrant minority communities in many developed countries has been low, it is increasing with greater exposure to Western lifestyle risks,⁴⁸ including growth in obesity,⁴⁹ with growing evidence cancer rates are increasing for the same population (http://www.ncin.org.uk/view?rid=2223). Yet referral patterns to cancer genetics services have changed little.⁵⁰ The issue of familial risk may commonly be initiated by individuals presenting concern to their primary care providers, particularly among those who are asymptomatic and white.⁵¹ Combinations of less community knowledge or experience of cancer, stigma and sometimes lower educational opportunity may mean individuals from minority ethnic communities remain less aware of the potential relevance to their health of family history or risk of cancer. They may be reluctant or less empowered to seek information or advice from providers. These delays in presentation are often compounded by the need for a higher number of primary care practitioner appointments prior to a referral for potential cancer diagnostic investigations.⁵² These barriers may combine resulting in a later diagnosis with consequences for treatment.⁵³

The current evidence underlines need for interventions that involve proactive provision of familial cancer risk information and assessment opportunities, and evaluation of their clinical and cost-effectiveness. Communities in more socially deprived settings might form a particular priority. This could include community awareness raising, use of outreach and patient self-referral, building on the promise of emerging culturally adapted service and nurse led models.^{22, 25, 30} The advantages of closer integration between ‘non-specialist' primary or cancer care providers and specialist genetics services should be exploited.^{1, 25, 29, 30} This should include systematic ethnicity monitoring to assist not only audit of access but also tracking of tumour incidence and survival among minority communities.^{1, 54} Parallel priorities are specific training of both interpreters and health providers in achieving successful triadic cross-cultural communication, recognising the particular challenges of doing so when discussing not only cancer⁵⁵ but also the complexities of inheritance, genetic risk, testing and screening.

Access to appropriate assessment may also be shaped by professionals' awareness of familial cancer risk. Providers in primary care⁵⁶ and the range of physicians or surgeons in cancer care⁵⁷ may feel they lack adequate genetic knowledge or skills in this area. This, and challenges of communication, including language barriers, may be one reason those from ethnic minorities appear less likely to be referred to cancer genetics services. Interventions should consider how providers might be better supported to initiate familial cancer risk assessment and genetics referral.

For cancer genetics providers, exploration of approaches that reduce barriers at initial stages of triaging risk, and targeting of culturally sensitive support for individuals to better understand their risk and options are needed. This should include facilitating communication of relevant information within families, given the cultural reluctance²⁴ and stigma that may pose barriers to doing so found in the current studies^{22, 23, 27, 29} and elsewhere.⁵⁸

Given the relative lack of research, greater understanding of the perspectives of minority ethnic people at familial cancer risk, those experiencing cancer genetics services and the range of providers involved is still needed to refine our knowledge of what shapes, and may enhance access and outcomes. This should include identifying learning from studies in other service settings, including those in non-English-speaking countries not included in this paper. Further qualitative research, including direct observation of encounters, could inform and assess the range of service development approaches suggested, prior to their further evaluation in experimental designs. In particular, a more comprehensive understanding of what happens at the differing points of access and interaction across the care pathway is required at community, cancer care and genetic service levels. The challenges for achieving more equitable and effective cancer genetics care remain considerable, but tackling them will be vital to benefit growing proportions of our populations.

The authors declare no conflict of interest.